Swab test could spot hidden uterine cancer early
NCT ID NCT07544680
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This study is collecting vaginal fluid samples from 4,200 people to develop a new test for endometrial cancer. Participants include those with abnormal uterine bleeding or a recent endometrial cancer diagnosis. The goal is to find biomarkers that could lead to a simple, non-invasive screening tool.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABNORMAL UTERINE BLEEDING (AUB) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IC Research
RECRUITINGMurfreesboro, Tennessee, 37132, United States
-
MaineHealth
RECRUITINGScarborough, Maine, 04070, United States
-
Murfreesboro Medical Clinic
RECRUITINGMurfreesboro, Tennessee, 37130, United States
-
Physical Care Clinical Research
RECRUITINGSarasota, Florida, 34249, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can immunotherapy plus hormones spare the womb in early endometrial cancer?
- Can a new drug tackle Hard-to-Treat gynecologic cancers?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Could gentle yoga and breathing ease Cancer's lingering toll?